Scientists Map How DNA Damage Triggers a Double Chemical Tag on Histones
Researchers identify a novel dual modification—ADP-ribosylation plus ubiquitylation—on histones and PARP1 after DNA damage, revealing a new layer of cellular signaling.
Summary
A team at the Max Planck Institute for Biology of Ageing has discovered that serine ADP-ribosylation (Ser-ADPr), a DNA-damage-induced chemical tag placed on histones and PARP1 by the enzyme PARP1/HPF1, is itself a substrate for a second modification: ester-linked ubiquitylation. Using custom proteomics tools and a novel enrichment strategy built around the RNF114 protein's dual-recognition domains, they pinpointed exact sites on histones and PARP1 where this rare composite modification occurs. They also engineered a detection reagent enabling routine laboratory identification of this dual mark. The findings establish ADP-ribosyl-ubiquitylation as a genuine endogenous post-translational modification and open new avenues for understanding DNA repair, chromatin regulation, and potentially aging-related cellular processes.
Detailed Summary
**Why this matters:** Post-translational modifications (PTMs) are chemical tags that dramatically expand protein function beyond what genes encode. When two distinct PTMs interact chemically on the same site, they create composite signals of outsized complexity. This study reveals such a signal—ester-linked ubiquitylation of ADP-ribose on serine residues—as a genuine cellular event triggered by DNA damage, a process deeply relevant to genome stability and aging.
**What was studied:** The researchers focused on RNF114, an E3 ubiquitin ligase recruited to DNA lesions via two distinct binding domains: a zfDi19 domain that recognizes mono-ADP-ribose (mono-ADPr) and a ubiquitin interaction motif (UIM) that binds ubiquitin. By mapping RNF114's interaction partners under DNA damage conditions (H₂O₂ treatment in U2OS cells), they identified the DELTEX-family E3 ligase DTX3L as a key binding partner, suggesting RNF114 might be reading a composite ADPr-ubiquitin signal. They then developed a multi-pronged proteomics strategy to identify exactly where this dual modification occurs in cells.
**Key results:** The team identified the E3 ligase DTX3L—known to catalyze ester-linked ubiquitylation of ADP-ribose in biochemical assays—as a DNA-damage-dependent interactor of RNF114. Using an enrichment method based on the combined zfDi19 and UIM domains (termed ZUD) of RNF114, with specific EDTA-mediated chemical elution to disrupt zinc-dependent mono-ADPr binding, they isolated and mapped ADP-ribosyl-ubiquitylated peptides from cells. Proteomics strategies tailored to the unique mass signatures of this composite PTM—including open database searches for combined delta masses and inspection of diagnostic fragmentation ions—identified modification sites on histones (including H2B and H3) and on PARP1 itself. They also engineered ZUD into a modular SpyTag-based reagent enabling western blot detection of this dual modification, confirming its presence in cells by orthogonal means.
**Implications:** This work establishes serine ADP-ribosyl-ubiquitylation as an endogenous PTM operating within the PARP1 DNA-damage response pathway. The finding that histones and PARP1—both central regulators of chromatin and genome integrity—carry this composite mark suggests it may influence chromatin remodeling, DNA repair efficiency, and the resolution of the damage response. Given that PARP1 activity and its regulation are closely tied to aging phenotypes and age-related diseases including cancer and neurodegeneration, this newly characterized signaling layer may have broad biomedical relevance.
**Caveats:** The study demonstrates the existence and sites of this composite modification but does not yet fully characterize its functional consequences or the enzymatic machinery that reverses it. The modification appears at low stoichiometry, making detection technically demanding and leaving open questions about its prevalence across cell types, tissues, and physiological stressors beyond H₂O₂ treatment.
Key Findings
- RNF114's dual domains (zfDi19 + UIM) read a composite serine ADP-ribosyl-ubiquitin signal on DNA-damaged chromatin.
- DTX3L E3 ligase was confirmed as a DNA-damage-dependent RNF114 interactor, linking it to ester-linked ubiquitylation of ADPr.
- Specific modification sites of ADP-ribosyl-ubiquitylation were mapped on histones H2B, H3, and on PARP1 in living cells.
- A novel ZUD-based enrichment and EDTA chemical elution strategy enabled proteomics-grade detection of this rare composite PTM.
- A SpyTag-engineered ZUD reagent allows routine western blot detection of cellular ADP-ribosyl-ubiquitylation.
Methodology
The study used inducible GFP-tagged RNF114 wild-type and C176A mutant cell lines in U2OS cells, combined with H₂O₂-induced DNA damage and GFP pulldown followed by DIA quantitative proteomics. A custom enrichment strategy using the ZUD domain with EDTA-based chemical elution, open-mass-shift database searches, and HCD diagnostic ion analysis identified ADP-ribosyl-ubiquitylation sites; a SpyTag-ZUD fusion was validated by western blot as an orthogonal detection tool.
Study Limitations
The study characterizes modification sites but does not define the functional consequence of ADP-ribosyl-ubiquitylation on chromatin or PARP1 activity. Detection relied primarily on H₂O₂-stressed U2OS cells, so prevalence under physiological stress or in primary tissues remains unknown. The low stoichiometry of the modification makes comprehensive site mapping technically challenging and likely incomplete.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: